Canada warns about drug mix-up caused by similar names

11/9/2011 | CBC.ca (Canada)

Health Canada said five cases have been reported this year involving a drug mix-up of Pradax, by Boehringer Ingelheim, and Plavix, by Sanofi and Bristol-Myers Squibb, because of their similar trade names. One case resulted in nonserious bleeding after a medical procedure. Taking one drug when the other is prescribed could increase the risk of bleeding, heart attack or blood clots, the health agency said.

View Full Article in:

CBC.ca (Canada)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC